O	0	12	Transporters	Transporter	NNS	B-NP
O	12	13	,	,	,	O
O	14	21	enzymes	enzyme	NNS	B-NP
O	21	22	,	,	,	O
O	23	26	and	and	CC	O
O	27	36	enalapril	enalapril	NN	B-NP
O	37	44	removal	removal	NN	I-NP
O	45	47	in	in	IN	B-PP
O	48	49	a	a	DT	B-NP
O	50	53	rat	rat	NN	I-NP
O	54	55	(	(	(	O
B-Cell	55	60	CC531	CC531	NN	B-NP
O	60	61	-	-	HYPH	B-VP
O	61	68	induced	induce	VBN	I-VP
O	68	69	)	)	)	O
B-Organ	70	75	liver	liver	NN	B-NP
O	76	86	metastatic	metastatic	JJ	I-NP
O	87	92	model	model	NN	I-NP
O	92	93	.	.	.	O

O	95	103	Temporal	Temporal	JJ	B-NP
O	104	111	changes	change	NNS	I-NP
O	112	114	in	in	IN	B-PP
O	115	128	physiological	physiological	JJ	B-NP
O	129	135	spaces	space	NNS	I-NP
O	135	136	,	,	,	O
O	137	144	protein	protein	NN	B-NP
O	145	155	expression	expression	NN	I-NP
O	156	158	of	of	IN	B-PP
O	159	171	transporters	transporter	NNS	B-NP
O	172	175	and	and	CC	I-NP
O	176	183	enzymes	enzyme	NNS	I-NP
O	183	184	,	,	,	O
O	185	188	and	and	CC	O
O	189	198	enalapril	enalapril	NN	B-NP
O	199	206	removal	removal	NN	I-NP
O	207	211	were	be	VBD	B-VP
O	212	221	appraised	appraise	VBN	I-VP
O	222	224	in	in	IN	B-PP
O	225	228	the	the	DT	B-NP
B-Cancer	229	239	metastatic	metastatic	JJ	I-NP
I-Cancer	240	245	liver	liver	NN	I-NP
I-Cancer	246	251	tumor	tumor	NN	I-NP
O	252	257	model	model	NN	I-NP
O	258	267	developed	develop	VBN	B-VP
O	268	272	from	from	IN	B-PP
O	273	277	male	male	JJ	B-NP
O	278	281	Wag	Wag	NN	I-NP
O	281	282	/	/	SYM	B-VP
O	282	285	Rij	Rij	NN	B-NP
O	286	290	rats	rat	NNS	I-NP
O	291	296	after	after	IN	B-PP
O	297	300	the	the	DT	B-NP
O	301	312	intraportal	intraportal	JJ	I-NP
O	313	322	injection	injection	NN	I-NP
O	323	325	of	of	IN	B-PP
B-Cell	326	331	CC531	CC531	NN	B-NP
I-Cell	332	337	colon	colon	NN	I-NP
I-Cell	338	352	adenocarcinoma	adenocarcinoma	NN	I-NP
I-Cell	353	358	cells	cell	NNS	I-NP
O	358	359	;	;	:	O
O	360	364	sham	sham	NN	B-NP
O	364	365	-	-	HYPH	B-NP
O	365	373	operated	operate	VBN	I-NP
O	374	386	preparations	preparation	NNS	I-NP
O	387	395	received	receive	VBD	B-VP
O	396	399	PBS	PBS	NNP	B-NP
O	399	400	.	.	.	O

B-Tissue	401	406	Liver	Liver	NN	B-NP
I-Tissue	407	413	tissue	tissue	NN	I-NP
O	414	420	spaces	space	NNS	I-NP
O	420	421	,	,	,	O
O	422	434	investigated	investigate	VBN	B-VP
O	435	439	with	with	IN	B-PP
O	440	448	multiple	multiple	JJ	B-NP
O	449	458	indicator	indicator	NN	I-NP
O	459	467	dilution	dilution	NN	I-NP
O	468	477	technique	technique	NN	I-NP
O	478	480	in	in	IN	B-PP
B-Organ	481	486	liver	liver	NN	B-NP
O	487	496	perfusion	perfusion	NN	I-NP
O	497	504	studies	study	NNS	I-NP
O	504	505	,	,	,	O
O	506	510	were	be	VBD	B-VP
O	511	520	unchanged	unchanged	JJ	B-ADJP
O	521	523	at	at	IN	B-PP
O	524	528	week	week	NN	B-NP
O	529	530	3	3	CD	I-NP
O	531	536	after	after	IN	B-PP
B-Cancer	537	542	tumor	tumor	NN	B-NP
O	543	552	induction	induction	NN	I-NP
O	552	553	.	.	.	O

O	554	556	At	At	IN	B-PP
O	557	561	week	week	NN	B-NP
O	562	563	4	4	CD	I-NP
O	563	564	,	,	,	O
O	565	572	however	however	RB	B-ADVP
O	572	573	,	,	,	O
O	574	577	the	the	DT	B-NP
B-Multi-tissue_structure	578	588	sinusoidal	sinusoidal	JJ	I-NP
I-Multi-tissue_structure	589	594	blood	blood	NN	I-NP
O	595	601	volume	volume	NN	I-NP
O	602	605	and	and	CC	I-NP
O	606	613	albumin	albumin	NN	I-NP
O	614	619	Disse	Disse	NNP	I-NP
O	620	625	space	space	NN	I-NP
O	626	628	in	in	IN	B-PP
B-Cancer	629	634	tumor	tumor	NN	B-NP
O	634	635	-	-	HYPH	O
O	635	642	bearing	bear	VBG	B-NP
B-Organ	643	649	livers	liver	NNS	I-NP
O	650	654	were	be	VBD	B-VP
O	655	663	slightly	slightly	RB	B-ADJP
O	664	669	lower	low	JJR	I-ADJP
O	670	678	compared	compare	VBN	B-PP
O	679	683	with	with	IN	B-PP
O	684	689	those	those	DT	B-NP
O	690	692	of	of	IN	B-PP
O	693	698	shams	sham	NNS	B-NP
O	698	699	.	.	.	O

O	700	709	Increased	Increase	VBN	B-NP
O	710	716	levels	level	NNS	I-NP
O	717	719	of	of	IN	B-PP
O	720	723	the	the	DT	B-NP
B-Multi-tissue_structure	724	735	canalicular	canalicular	JJ	I-NP
O	736	739	ATP	ATP	NN	I-NP
O	740	752	transporters	transporter	NNS	I-NP
O	752	753	,	,	,	O
O	754	755	P	P	NN	B-NP
O	755	756	-	-	HYPH	I-NP
O	756	768	glycoprotein	glycoprotein	NN	I-NP
O	768	769	,	,	,	O
O	770	779	multidrug	multidrug	JJ	B-NP
O	780	790	resistance	resistance	NN	I-NP
O	790	791	-	-	HYPH	O
O	791	801	associated	associate	VBN	B-VP
O	802	809	protein	protein	NN	B-NP
O	810	811	2	2	CD	I-NP
O	812	813	(	(	(	O
O	813	817	Mrp2	Mrp2	NN	B-NP
O	817	818	)	)	)	O
O	818	819	,	,	,	O
O	820	823	and	and	CC	O
O	824	828	bile	bile	NN	B-NP
O	829	833	salt	salt	NN	I-NP
O	834	840	export	export	NN	I-NP
O	841	845	pump	pump	NN	I-NP
O	846	847	(	(	(	O
O	847	851	Bsep	Bsep	NN	B-NP
O	851	852	)	)	)	O
O	853	855	at	at	IN	B-PP
O	856	860	week	week	NN	B-NP
O	861	862	2	2	CD	I-NP
O	863	864	(	(	(	O
O	864	865	P	P	NN	B-NP
O	866	867	<	<	SYM	B-ADJP
O	868	869	0	0	CD	B-NP
O	869	870	.	.	.	I-NP
O	870	872	05	05	CD	I-NP
O	872	873	)	)	)	O
O	873	874	,	,	,	O
O	875	884	unchanged	unchanged	JJ	B-NP
O	885	891	levels	level	NNS	I-NP
O	892	894	of	of	IN	B-PP
O	895	899	Ntcp	Ntcp	NN	B-NP
O	899	900	,	,	,	O
O	901	908	Oatp1a1	Oatp1a1	NN	B-NP
O	908	909	,	,	,	O
O	910	917	Oatp1a4	Oatp1a4	NN	B-NP
O	917	918	,	,	,	O
O	919	922	and	and	CC	O
O	923	927	Mct2	Mct2	NN	B-NP
O	927	928	,	,	,	O
O	929	932	but	but	CC	O
O	933	942	decreased	decrease	VBD	B-VP
O	943	949	levels	level	NNS	B-NP
O	950	952	of	of	IN	B-PP
O	953	963	cytochrome	cytochrome	NN	B-NP
O	964	968	P450	P450	NN	I-NP
O	969	972	3a2	3a2	NN	I-NP
O	973	974	(	(	(	O
O	974	980	Cyp3a2	Cyp3a2	NN	B-NP
O	980	981	)	)	)	O
O	982	985	and	and	CC	O
O	986	997	glutathione	glutathione	NN	B-NP
O	998	999	S	S	NN	I-NP
O	999	1000	-	-	HYPH	B-NP
O	1000	1011	transferase	transferase	NN	I-NP
O	1012	1013	(	(	(	O
O	1013	1017	Gst4	Gst4	NN	B-NP
O	1017	1018	-	-	HYPH	B-NP
O	1018	1019	4	4	CD	I-NP
O	1019	1020	)	)	)	O
O	1021	1023	at	at	IN	B-PP
O	1024	1028	week	week	NN	B-NP
O	1029	1030	4	4	CD	I-NP
O	1031	1032	(	(	(	O
O	1032	1033	P	P	NN	B-NP
O	1034	1035	<	<	SYM	B-ADJP
O	1036	1037	0	0	CD	B-NP
O	1037	1038	.	.	.	I-NP
O	1038	1040	05	05	CD	I-NP
O	1040	1041	)	)	)	O
O	1042	1046	were	be	VBD	B-VP
O	1047	1055	observed	observe	VBN	I-VP
O	1056	1058	in	in	IN	B-PP
B-Cell	1059	1068	peritumor	peritumor	NN	B-NP
O	1069	1071	vs	vs	CC	O
O	1071	1072	.	.	.	B-NP
O	1073	1077	sham	sham	NN	I-NP
O	1077	1078	-	-	HYPH	O
O	1078	1086	operated	operate	VBN	B-NP
B-Tissue	1087	1092	liver	liver	NN	I-NP
I-Tissue	1093	1100	tissues	tissue	NNS	I-NP
O	1101	1105	with	with	IN	B-PP
O	1106	1113	Western	Western	JJ	B-NP
O	1114	1122	blotting	blotting	NN	I-NP
O	1122	1123	.	.	.	O

O	1124	1127	The	The	DT	B-NP
O	1128	1134	steady	steady	JJ	I-NP
O	1134	1135	-	-	HYPH	I-NP
O	1135	1140	state	state	NN	I-NP
O	1141	1151	extraction	extraction	NN	I-NP
O	1152	1157	ratio	ratio	NN	I-NP
O	1158	1160	of	of	IN	B-PP
O	1161	1170	enalapril	enalapril	NN	B-NP
O	1170	1171	,	,	,	O
O	1172	1173	a	a	DT	B-NP
O	1174	1183	substrate	substrate	NN	I-NP
O	1184	1188	that	that	WDT	B-NP
O	1189	1195	enters	enter	VBZ	B-VP
O	1196	1199	the	the	DT	B-NP
B-Organ	1200	1205	liver	liver	NN	I-NP
O	1206	1213	rapidly	rapidly	RB	B-ADVP
O	1214	1217	via	via	IN	B-PP
O	1218	1225	Oatp1a1	Oatp1a1	NN	B-NP
O	1226	1229	and	and	CC	O
O	1230	1239	primarily	primarily	RB	B-VP
O	1240	1249	undergoes	undergo	VBZ	I-VP
O	1250	1260	metabolism	metabolism	NN	B-NP
O	1261	1263	by	by	IN	B-PP
O	1264	1267	the	the	DT	B-NP
O	1268	1285	carboxylesterases	carboxylesteras	NNS	I-NP
O	1285	1286	,	,	,	O
O	1287	1290	was	be	VBD	B-VP
O	1291	1301	unaffected	unaffected	JJ	B-ADJP
O	1302	1304	by	by	IN	B-PP
B-Organ	1305	1310	liver	liver	NN	B-NP
O	1311	1321	metastasis	metastasis	NN	I-NP
O	1322	1324	at	at	IN	B-PP
O	1325	1329	week	week	NN	B-NP
O	1330	1331	4	4	CD	I-NP
O	1332	1342	regardless	regardless	RB	B-ADVP
O	1343	1345	of	of	IN	B-PP
O	1346	1349	its	its	PRP$	B-NP
O	1350	1358	delivery	delivery	NN	I-NP
O	1359	1362	via	via	IN	B-PP
O	1363	1366	the	the	DT	B-NP
B-Multi-tissue_structure	1367	1373	portal	portal	JJ	I-NP
I-Multi-tissue_structure	1374	1378	vein	vein	NN	I-NP
O	1379	1381	or	or	CC	O
B-Multi-tissue_structure	1382	1389	hepatic	hepatic	JJ	B-NP
I-Multi-tissue_structure	1390	1396	artery	artery	NN	I-NP
O	1397	1401	into	into	IN	B-PP
O	1402	1405	the	the	DT	B-NP
O	1406	1414	perfused	perfuse	VBN	I-NP
B-Organ	1415	1420	liver	liver	NN	I-NP
O	1421	1433	preparations	preparation	NNS	I-NP
O	1433	1434	.	.	.	O

